ArticleBritish journal of pharmacology2022

Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition.

Chris Lindsay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.